OCT 10, 2021 5:10 AM PDT

DNA Can Reveal Treatments for Lung Cancer in 'Never-Smoked' Patients

WRITTEN BY: Carmen Leitch

There is a well-known causal connection between smoking and lung cancer, and most research on lung cancer has been focused on people with a history of tobacco use. But people that do not smoke can still get the disease. Researchers have been working to learn more about why that happens, and scientists have also found that genetics can play a role. A new study in the Journal of Clinical Oncology has suggested that it could be possible to treat 78 to 92 percent of lung cancers in 'never-smokers' with drugs that already exist and are approved for other uses.

 Credit  National Cancer Institute

Lung cancer in non-smokers can be promoted by so-called cancer-driving mutations in cancer cells. These genetic mutations can impact biochemical pathways in cells, and for many, there are already drugs that act on these pathways. This study indicated that most people who have never smoked but have lung cancer also carry driver mutations, but those mutations are only found in about half of lung cancer patients who were smokers.

Senior study author Ramaswamy Govindan, MD, a professor of medicine at the Washington University School of Medicine in St. Louis noted that the studies that have investigated lung cancer in never-smokers have not searched for mutations that might be targeted for treatment. This work shows it's possible with the right data.

"The patient must have a high-quality biopsy to make sure there is enough genetic material to identify key mutations. But testing these patients is critical. There is a high chance such patients will have an actionable mutation that we can go after with specific therapies,” said Govindan.

In this research, the scientists assessed lung adenocarcinomas from 160 people with no history of tobacco smoking. Mutation patterns were analyzed, and the study revealed that lung tumors in smokers have about ten times as many genetic mutations as never-smokers' tumors. Heavy exposure to tobacco smoke causes significant changes in cells, but those signs weren't found in never-smokers, said Govindan.

Interestingly, only about 7 percent of never-smoker lung cancer patients were born with genetic mutations predisposing them to developing the disease. It may be that researchers have not identified all of the genes that increase lung cancer risk, suggested Govindan.

“There appears to be something unique about lung cancer in people who have never smoked. We didn’t find a major role for inherited mutations, and we don’t see evidence of large numbers of mutations, which would suggest exposure to secondhand smoke."

This research also showed that the mutations in lung tumors of never-smokers don't usually involved immune genes, which can help explain why the patients sometimes aren't responsive to immunotherapies.

Sources: Washington University School of Medicine, Journal of Clinical Oncology

About the Author
  • Experienced research scientist and technical expert with authorships on over 30 peer-reviewed publications, traveler to over 70 countries, published photographer and internationally-exhibited painter, volunteer trained in disaster-response, CPR and DV counseling.
You May Also Like
OCT 21, 2021
Clinical & Molecular DX
Dementia Diagnostic Looks for 'Hungry' Immune Cells in the Brain
OCT 21, 2021
Dementia Diagnostic Looks for 'Hungry' Immune Cells in the Brain
Experts have long known that the immune cells in our brains called microglia are important for preserving neural tissue ...
OCT 25, 2021
Space & Astronomy
Spaceflight Seems to Raise Levels of Circulating Cell-Free Mitochondrial DNA
OCT 25, 2021
Spaceflight Seems to Raise Levels of Circulating Cell-Free Mitochondrial DNA
Spaceflight is being marketed as a tourist opportunity for extremely wealthy people, and lengthy space missions that cou ...
NOV 01, 2021
Cell & Molecular Biology
How SARS-CoV-2 Evades Antiviral Defenses
NOV 01, 2021
How SARS-CoV-2 Evades Antiviral Defenses
Researchers have learned a lot about the SARS-CoV-2 virus since the start of the COVID-19 pandemic. We know that he viru ...
NOV 11, 2021
Health & Medicine
The Taconic-Cyagen Academic Model Generation Alliance
NOV 11, 2021
The Taconic-Cyagen Academic Model Generation Alliance
With more than 15 years of experience in genetic engineering, Cyagen utilizes a highly efficient process, including prop ...
NOV 10, 2021
Cell & Molecular Biology
The Symmetry of Sea Stars Reveals More About Development
NOV 10, 2021
The Symmetry of Sea Stars Reveals More About Development
With time lapse photography, scientists have now learned more about the symmetry of sea stars. This work could tell us m ...
NOV 29, 2021
Microbiology
How the Hepatitis B Virus Promotes Liver Cancer Development
NOV 29, 2021
How the Hepatitis B Virus Promotes Liver Cancer Development
It's estimated that about 240 million people worldwide have an HBV infection. Hepatitis B infections are linked to t ...
Loading Comments...